May 20, 2020 / 12:02 PM / 17 days ago

BRIEF-Kindred Biosciences Reports Covid-19 Vaccine Manufacturing Agreement With Vaxart

May 20 (Reuters) - Kindred Biosciences Inc:

* KINDRED BIOSCIENCES ANNOUNCES COVID-19 VACCINE MANUFACTURING AGREEMENT WITH VAXART

* KINDRED BIOSCIENCES INC - KINDREDBIO WILL MANUFACTURE VACCINE FOR CLINICAL TRIALS BEGINNING IN SECOND HALF OF 2020

* KINDRED BIOSCIENCES - WILL PRODUCE CANDIDATE VACCINE BULK DRUG SUBSTANCE UNDER GOOD MANUFACTURING PRACTICES

* KINDRED BIOSCIENCES - CO WILL PRODUCE CANDIDATE VACCINE AND PROVIDE IT TO VAXART TO BE FORMULATED INTO A VACCINE TABLET Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below